Figure S6 from Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis

Charles H. Earnshaw; Poppy Dunn; Shih‐Chieh Chiang; Agrin Moeini; Maria A. Koufaki; Eduardo Bonavita; Massimo Russo; Laëtitia Nebot-Bral; Kimberley Hockenhull; Erin Richardson; Anna Pidoux; Charlotte R. Bell; Alexander R. Baker; Richard Reeves; Robert Sellers; Sudhakar Sahoo; Victoria Elisabeth Richardsdot Fife; Matthew G. Roberts; Theophile Bigirumurame; Caroline Dive; Julia Newton‐Bishop; Jérémie Nsengimana; Christopher E.M. Griffiths; Santiago Zelenay

doi:10.1158/2159-8290.31276869

Figure S6 from Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis

2026 Open access

Read full text

Authors: Charles H. Earnshaw, Poppy Dunn, Shih‐Chieh Chiang, Agrin Moeini, Maria A. Koufaki, Eduardo Bonavita, Massimo Russo, Laëtitia Nebot-Bral, Kimberley Hockenhull, Erin Richardson, Anna Pidoux, Charlotte R. Bell

+12 more

Alexander R. Baker, Richard Reeves, Robert Sellers, Sudhakar Sahoo, Victoria Elisabeth Richardsdot Fife, Matthew G. Roberts, Theophile Bigirumurame, Caroline Dive, Julia Newton‐Bishop, Jérémie Nsengimana, Christopher E.M. Griffiths, Santiago Zelenay

DOI: 10.1158/2159-8290.31276869

Cited by: 0

Abstract

Supplementary Figure 6. GC treatment spares intratumoral CD8+ T cells, resulting in an increased ratio of CD8+ T cells to Tregs.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology TGF-β signaling in diseases

Publication details

Publication date: 6 February 2026